Our team will closely work with you to develop your specific and sensitive immunoassay (following GxP guidelines) to support the research and clinical development of your drug candidates.
Our services:
|
- Radioimmunoassays (cell-based and non cell-based) |
|
- Method feasibility and development (RIA) |
|
- Method validation following ICH Q2 (R1) guidance documents and current GMP (including Specificity, Linearity, Repeatability and intermediate precision, Robustness) |
|
- Matrix (plasma, blood, urine, CSF...) |
|
- Different species available |